PYC Therapeutics (Australia) Market Value
| PYC Stock | 1.40 0.05 3.45% |
| Symbol | PYC |
PYC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PYC Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PYC Therapeutics.
| 01/05/2023 |
| 12/25/2024 |
If you would invest 0.00 in PYC Therapeutics on January 5, 2023 and sell it all today you would earn a total of 0.00 from holding PYC Therapeutics or generate 0.0% return on investment in PYC Therapeutics over 720 days. PYC Therapeutics is related to or competes with FSA, Tamawood, Cochlear, Rea, Macquarie, Block, and Pro Medicus. PYC Therapeutics is entity of Australia. It is traded as Stock on AU exchange. More
PYC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PYC Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PYC Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 25.32 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 5.71 |
PYC Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PYC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PYC Therapeutics' standard deviation. In reality, there are many statistical measures that can use PYC Therapeutics historical prices to predict the future PYC Therapeutics' volatility.| Risk Adjusted Performance | 0.0055 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | 0.1381 |
PYC Therapeutics Backtested Returns
PYC Therapeutics retains Efficiency (Sharpe Ratio) of -0.083, which implies the firm had a -0.083% return per unit of risk over the last 3 months. PYC Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PYC Therapeutics' coefficient of variation of (30,306), and Market Risk Adjusted Performance of 0.1481 to confirm the risk estimate we provide. The company owns a Beta (Systematic Risk) of -0.18, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PYC Therapeutics are expected to decrease at a much lower rate. During the bear market, PYC Therapeutics is likely to outperform the market. At this point, PYC Therapeutics has a negative expected return of -0.32%. Please make sure to check PYC Therapeutics' coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if PYC Therapeutics performance from the past will be repeated at future time.
Auto-correlation | 0.11 |
Insignificant predictability
PYC Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between PYC Therapeutics time series from 5th of January 2023 to 31st of December 2023 and 31st of December 2023 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PYC Therapeutics price movement. The serial correlation of 0.11 indicates that less than 11.0% of current PYC Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
PYC Therapeutics lagged returns against current returns
Autocorrelation, which is PYC Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PYC Therapeutics' stock expected returns. We can calculate the autocorrelation of PYC Therapeutics returns to help us make a trade decision. For example, suppose you find that PYC Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PYC Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PYC Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PYC Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PYC Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
PYC Therapeutics Lagged Returns
When evaluating PYC Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PYC Therapeutics stock have on its future price. PYC Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PYC Therapeutics autocorrelation shows the relationship between PYC Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in PYC Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.